Section Arrow
JANX.NASDAQ
- Janux Therapeutics
Quotes are at least 15-min delayed:2026/06/03 14:31 EDT
Regular Hours
Last
 13.62
-0.16 (-1.16%)
Day High 
13.77 
Prev. Close
13.78 
1-M High
14.87 
Volume 
333.26K 
Bid
13.61
Ask
13.63
Day Low
13.505 
Open
13.65 
1-M Low
13.41 
Market Cap 
840.36M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 14.35 
20-SMA 14.34 
50-SMA 14.5 
52-W High 35.34 
52-W Low 12.12 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.84/-2.44
Enterprise Value
860.11M
Balance Sheet
Book Value Per Share
15.44
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.00M
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.095-0.0148-13.48%-- 
CLDICalidi Biotherapeutics0.1635-0.0166-9.22%-- 
RXRXRecursion Pharmaceuticals3.455-0.155-4.29%-- 
OTLKOutlook Therapeutics0.802599-0.011001-1.35%-- 
GOSSGossamer Bio0.1883-0.0119-5.94%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.